BethAnn Telford, a brain cancer survivor and Ironman athlete, is the inspiration behind the summer hotel promotion.
In May, our San Diego gathering featured a discussion with leading academic and industry brain cancer researchers.
A message from Max Wallace, CEO of Accelerate Brain Cancer Cure.
Over $22 Million Raised Since 1998; American Idol® David Cook Returns as Honorary Chair
More than 1400 participants, 73 teams and dozens of sponsors raised $209,000 for brain cancer research in the state of Florida.
ABC2's Max Wallace leads the NCI's Director's Consumer Liaison Group that addresses research issues critical to improving outcomes for patients with all types of cancers.
The coalition includes Accelerate Brain Cancer Cure, the Musella Foundation for Brain Tumor Research and Information, the National Brain Tumor Society and the Society for Neuro-Oncology.
An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM. ABC2's petitioning of the FDA is noted.
An interview with biogeneticist Eric S. Lander in the January/February issue of The Atlantic.
Dr. Shawn Carbonell is OncoSynergy's CEO and his wife, Dr. Anne-Marie Carbonell, is the VP of Clinical Development. OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.
Recurrent Brain Cancers Follow Distinctive Genetic Paths, UCSF Team Shows Commonly Used Brain Tumor Chemotherapy Agent May Propel Recurrent Tumors to Malignancy
Enjoy discounted seats at the Miami HEAT game on January 21st and support brain cancer research.
The latest update on the UF pediatric research project funded by Accelerate Brain Cancer Cure, Paul Hale and the Florida Brain Tumor Association.
Cara Perellis, Project Manager at the Case Foundation, shares why she took a 365 foot plunge off the tallest building in San Diego!
The proceeds of the charity tournament support Accelerate Brain Cancer Cure's collaborative research funding at University of Florida.
With the support of many friends, co-workers and family, our team has raised over $59,000 for brain tumor research.
The Phase II trial is led by Dr. Duane Mitchell, director of the UF Brain Tumor Immunotherapy Program.
Key industry and foundation leaders were invited to share their disruptive ideas on the future of neurosurgery at the new CNS Neurosurgery Innovations Symposium.
A letter to the brain tumor community from Max Wallace, CEO of Accelerate Brain Cancer Cure.
The NCI/ABC2 meeting in September discussed how a powerful new class of immunotherapy drugs--PD-1 inhibitors--might be used to treat glioma. This New York Times article does a good job explaining the rationale behind the approach.
The Oct. 10 issue of Cell looks at the progress made by The Cancer Genome Atlas since its launch five years ago.
Brain cancer survivors and VIPs to rappel down tallest building in San Diego on November 2 and 3 - all proceeds to benefit brain cancer research.
While the honorees expressed gratitude for the prize, their comments about their work were tinged with worry about the future of biomedical research after years of cuts in federal funding.
The researchers caution that many treatments have cured cancers in mice and then failed in humans. But they are encouraged by the new findings and want to work quickly to design a clinical trial for humans.
Accelerate Brain Cancer Cure helped fund the Phase 2 trial led by Dr. Andrew Parsa, Chair of Neurosurgery at Northwestern Memorial Hospital.